scholarly article | Q13442814 |
P2093 | author name string | van Geel A | |
Heyndrickx L | |||
Willems B | |||
Bernaerts R | |||
Vanderborght B | |||
Nijs P | |||
Saman E | |||
De Leys R | |||
Wauters C | |||
Vanden Haesevelde M | |||
P2860 | cites work | Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS) | Q22242256 |
Characterization of antigen receptor response elements within the interleukin-2 enhancer | Q24632042 | ||
Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS | Q28262859 | ||
Nucleotide sequence of the AIDS virus, LAV | Q28286313 | ||
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS | Q29614260 | ||
Regulation of interleukin 2 receptor alpha subunit (Tac or CD25 antigen) gene expression: binding of inducible nuclear proteins to discrete promoter sequences correlates with transcriptional activation | Q33582617 | ||
Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding | Q33684251 | ||
Isolation of a new human retrovirus from West African patients with AIDS. | Q34038984 | ||
Isolation of T-cell tropic HTLV-III-like retrovirus from macaques | Q34049156 | ||
Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS | Q34055350 | ||
Identification of a putative regulator of early T cell activation genes | Q34171263 | ||
Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS | Q34250436 | ||
Comparison of simian immunodeficiency virus isolates | Q36415799 | ||
Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses | Q36881478 | ||
Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys | Q37412768 | ||
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation | Q38345116 | ||
Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus | Q38348287 | ||
HIV-2, the West African AIDS virus. | Q39601495 | ||
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. | Q40126058 | ||
AIDS in Africa: an epidemiologic paradigm | Q41345106 | ||
Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. | Q42735234 | ||
Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. | Q43858457 | ||
Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat | Q44646653 | ||
Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome | Q45807119 | ||
Isolation of human immunodeficiency virus type 2 from a homosexual man in Belgium. | Q45833716 | ||
Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines | Q45838115 | ||
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). | Q45838359 | ||
Virus related to but not identical with LAV/HTLV-III in Cameroon | Q45840155 | ||
Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa | Q45840185 | ||
Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates | Q45847816 | ||
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients | Q45848343 | ||
Characterization of long terminal repeat sequences of HTLV-III. | Q48381873 | ||
HIV infection in Nigeria. | Q50693862 | ||
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire. | Q53896192 | ||
Regulation of human interleukin-2 gene: functional DNA sequences in the 5' flanking region for the gene expression in activated T lymphocytes. | Q55243823 | ||
Genomic variability of selected LAV-related AIDS retroviruses. | Q55244360 | ||
Effects of the modification of transfer buffer composition and the renaturation of proteins in gels on the recognition of proteins on Western blots by monoclonal antibodies | Q68906766 | ||
Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals | Q68943219 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1207-1216 | |
P577 | publication date | 1990-03-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin | |
P478 | volume | 64 |
Q37062237 | A highly heterogeneous HIV-1 epidemic in the Central African Republic |
Q36629118 | A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon |
Q33785338 | Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. |
Q37333651 | Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. |
Q30701330 | Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data |
Q39449534 | Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target |
Q36575941 | Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR |
Q45770212 | Fast analysis of genomic homologies: primate immunodeficiency virus |
Q33652911 | Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs |
Q30390449 | Genomic Diversity of Human Immunodeficiency Viruses |
Q36629169 | Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate |
Q33271774 | Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat |
Q31066870 | Going wild: lessons from naturally occurring T-lymphotropic lentiviruses |
Q36376394 | HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges |
Q35852493 | Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program. |
Q36575121 | Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay |
Q46711304 | Multicentre study for diagnostic evaluation of an assay for simultaneous detection of antibodies to HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0). |
Q37586704 | Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon |
Q30420728 | Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. |
Q30432689 | Non-M variants of human immunodeficiency virus type 1. |
Q33972312 | One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AG |
Q26849291 | Origin and diversity of human retroviruses |
Q22242661 | Origins of HIV and the AIDS pandemic |
Q39455338 | Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2. |
Q45203052 | Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia |
Q33686306 | Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2. |
Q30342738 | Recombinant viruses and early global HIV-1 epidemic |
Q35125087 | Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso |
Q36891692 | Segregation of human immunodeficiency virus type 1 subtypes by risk factor in Australia |
Q44079254 | Specificity of new peptide immunoassays versus other immunoassays and agglutination tests for detection of HIV antibody in African Sera |
Q24630462 | Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis |
Q24545695 | The molecular population genetics of HIV-1 group O |
Q30417537 | Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France |
Search more.